Pure Global
PACTR201902485435341

Hot Cross-linking (Iqbal CXL)

Evaluation of a New Technique to Increase The Corneal Cross-linking Efficacy by Raising The Corneal Temperature During Ultra-Violet Light A Corneal Irradiation (Hot Cross-linking) for Kearatoconus Treatment
MOHAMMED IQBAL; Ahmed Elmassry·Not Applicable·Pan Africa Clinical Trials Registry·procedureRecruiting
Study focus
Disease/Condition
Eye Diseases
Intervention type
procedure
Sponsor & location
Primary sponsor
MOHAMMED IQBAL; Ahmed Elmassry
Funder
Mohammed Iqbal
Location
Egypt
Timeline & enrollment
Phase
Not Applicable
Start date
Jan 01, 1900
End date
Jan 01, 1900
Summary

Cornea Is resistant to destruction by cold (up to -70°C) and heat (up to +80°C). lowering the corneal temperature before CXL may increase oxygen diffusion into the cornea thus increasing CXL efficacy. However, the new idea of hot CXL proposed by Professor Mohammed Iqbal is to increase the corneal temperature during CXL to reach from 38°C to 39°C to test the corneal behavior and response to CXL in such high temperature.

ICD-10 classifications
Disorders of eyelid in diseases classified elsewhereOther disorders of eyelidOther specified disorders of eyelidInvolvement of eyelid in other diseases classified elsewhereDisorder of eyelid, unspecified
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR201902485435341
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR201902485435341 through Pure Global AI's free database. This Not Applicable trial is sponsored by MOHAMMED IQBAL; Ahmed Elmassry and is currently Recruiting. The study focuses on Eye Diseases.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.